Could a common antifungal keep Crohn's away after surgery?
NCT ID NCT02997059
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the antifungal drug fluconazole could lower levels of certain antibodies (ASCA) and prevent Crohn's disease from returning after bowel surgery. Thirty-five adults with Crohn's disease who had recent ileal or ileocecal resection were randomly assigned to receive fluconazole or a placebo for six months. The goal was to see if targeting a yeast in the gut could reduce inflammation and recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE AGGRAVATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU, Hôpital Claude Huriez
Lille, France